twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2019
vol. 121
 
Share:
Share:
abstract:
Review paper

The Current Knowledge on Navigated Retinal Laser Therapy (Navilas)

Ewelina Lachowicz
1
,
Wojciech Lubiński
1

1.
II Katedra i Klinika Okulistyki Pomorskiego Uniwersytetu Medycznego, Samodzielny Publiczny Szpital Kliniczny nr 2 w Szczecinie Kierownik: prof. dr hab. n. med. Wojciech Lubiński
Online publish date: 2020/03/31
View full text Get citation
 
PlumX metrics:
Digital systems supporting laser therapy enabled the introduction of new quality �navigated laser therapy for the treatment of retinal diseases. Navilas is the first and so far the only camera in the world that uses this technology and allows for standardized management. The used wavelength (577 nm �yellow) is currently recommended for retinal diseases treatment. The microsecond pulse mode additionally gives the possibility of the therapy of subfoveal and peri-foveal lesions. By using the innovative technology Navilas significantly exceeds conventional laser therapy. The system offers high precision and long-lasting satisfactory therapeutic effect with an increased level of safety. Navigated retinal laser therapy was used till now in: the central retinal vein or its branches occlusion, proliferative diabetic retinopathy, diabetic macular edema, central serous chorioretinopathy, macroadenomas, retinal telangiectasias, polyploidal choroidal vasculopathy, and in case of peripheral changes. Navigated therapy has the potential possibility to replace traditional laser therapy in many retinal diseases.
keywords:

NAVILAS, navigated laser, yellow laser photocoagulation, microsecond laser therapy

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.